The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Discovery and development of clofarabine: a nucleoside analogue for treating cancer
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
International Conference on Harmonisation
Guy, R. C. (2014) · Encyclopedia of Toxicology · doi:10.1016/b978-0-12-386454-3.00861-7 · Cited by 1,478
Mammalian deoxyribonucleoside kinases
Arnér, E. S. J., & Eriksson, S. (1995) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(95)00015-9 · Cited by 577
Nachman, J. B., Sather, H. N., Sensel, M. G., Trigg, M. E., Cherlow, J. M., Lukens, J. N., Wolff, L., Uckun, F. M., & Gaynon, P. S. (1998) · New England Journal of Medicine · doi:10.1056/nejm199806043382304 · Cited by 445
Pui, C.-H. (1995) · New England Journal of Medicine · doi:10.1056/nejm199506153322407 · Cited by 379
Sierra, J., Storer, B., Hansen, J. A., Bjerke, J. W., Martin, P. J., Petersdorf, E. W., Appelbaum, F. R., Bryant, E., Chauncey, T. R., Sale, G., et al. (1997) · Blood · doi:10.1182/blood.v89.11.4226 · Cited by 373
Nucleoside transporters: molecular biology and implications for therapeutic development
Baldwin, S. A., Mackey, J. R., Cass, C. E., & Young, J. D. (1999) · Molecular Medicine Today · doi:10.1016/s1357-4310(99)01459-8 · Cited by 349
Kantarjian, H., Gandhi, V., Cortes, J., Verstovsek, S., Du, M., Garcia-Manero, G., Giles, F., Faderl, S., O'Brien, S., Jeha, S., et al. (2003) · Blood · doi:10.1182/blood-2003-03-0925 · Cited by 314
Jeha, S., Gaynon, P. S., Razzouk, B. I., Franklin, J., Kadota, R., Shen, V., Luchtman-Jones, L., Rytting, M., Bomgaars, L. R., Rheingold, S., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.8554 · Cited by 308
Self-citationGenini, D., Adachi, S., Chao, Q., Rose, D. W., Carrera, C. J., Cottam, H. B., Carson, D. A., & Leoni, L. M. (2000) · Blood · doi:10.1182/blood.v96.10.3537 · Cited by 290
Clofarabine, a novel nucleoside analog, is active in pediatric patients with advanced leukemia
Jeha, S., Gandhi, V., Chan, K. W., McDonald, L., Ramirez, I., Madden, R., Rytting, M., Brandt, M., Keating, M., Plunkett, W., et al. (2004) · Blood · doi:10.1182/blood-2003-06-2122 · Cited by 256
Barrett, A. J., Horowitz, M. M., Pollock, B. H., Zhang, M.-J., Bortin, M. M., Buchanan, G. R., Camitta, B. M., Ochs, J., Graham-Pole, J., Rowlings, P. A., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199411103311902 · Cited by 237
Parker, W. B., Shaddix, S. C., Chang, C., White, E. L., Rose, L. M., Brockman, R. W., Shortnacy, A. T., Montgomery, J. A. J., Secrist, J. A. I., & Bennett, L. L. (1991) · PubMed · Cited by 207
Self-citationKantarjian, H. M., Gandhi, V., Kozuch, P., Faderl, S., Giles, F., Cortes, J., O’Brien, S., Ibrahim, N., Khuri, F., Du, M., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.04.031 · Cited by 192
Fifty Years of Studies of the Biology and Therapy of Childhood Leukemia
Kersey, J. H. (1997) · Blood · doi:10.1182/blood.v90.11.4243.4243_4243_4251 · Cited by 180
Carson, D. A., Wasson, D. B., Esparza, L. M., Carrera, C. J., Kipps, T. J., & Cottam, H. B. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.7.2970 · Cited by 158
Xie, K. C., & Plunkett, W. K. (1996) · PubMed · Cited by 133
Nachman, J. B., Sather, H. N., Gaynon, P. S., Lukens, J. N., Wolff, L. J., & Trigg, M. E. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.6.2222 · Cited by 120
Xie, C., & Plunkett, W. K. (1995) · PubMed · Cited by 107
New Drug Development: A Regulatory Overview
Valentino, J. G. (1987) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600761024 · Cited by 67
New Drug Development: A Regulatory Overview
Mathieu, M. P. (1990) · Cited by 66
New targets for pyrimidine antimetabolites in the treatment of solid tumours
van der Wilt, C. L., & Peters, G. J. (1994) · Pharmacy World & Science · doi:10.1007/bf01880660 · Cited by 54
Waud, W. R., Schmid, S. M., Montgomery, J. A. J., & Secrist, J. A. I. (2000) · Nucleosides Nucleotides & Nucleic Acids · doi:10.1080/15257770008033020 · Cited by 51
Self-citationNew targets for pyrimidine antimetabolites for the treatment of solid tumours
van Haperen, V. W. T. R., & Peters, G. J. (1994) · Pharmacy World & Science · doi:10.1007/bf01880661 · Cited by 34
THE DISTRIBUTION, METABOLISM, AND ELIMINATION OF CLOFARABINE IN RATS
Bonate, P. L., Arthaud, L. E., Stuhler, J., Yerino, P., Press, R. J., & Rose, J. Q. (2005) · Drug Metabolism and Disposition · doi:10.1124/dmd.104.002592 · Cited by 25
Self-citation
Cited by
Anand, U., Dey, A., Chandel, A. K. S., Sanyal, R., Mishra, A., Pandey, D. K., De Falco, V., Upadhyay, A., Kandimalla, R., Chaudhary, A., et al. (2023) · Genes & Diseases · doi:10.1016/j.gendis.2022.02.007 · Cited by 1,834
Enzymology of purine and pyrimidine antimetabolites used in the treatment of cancer
Parker, W. B. (2009) · Chemical Reviews · doi:10.1021/cr900028p · Cited by 622
Ribonucleotide reductase and cancer: biological mechanisms and targeted therapies
Aye, Y., Li, M., Long, M. J. C., & Weiss, R. S. (2015) · Oncogene · doi:10.1038/onc.2014.155 · Cited by 436
Shelton, J., Lu, X., Hollenbaugh, J. A., Cho, J. H., Amblard, F., & Schinazi, R. F. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00209 · Cited by 409
DNA repair mechanisms in cancer development and therapy
Torgovnick, A., & Schumacher, B. (2015) · Frontiers in Genetics · doi:10.3389/fgene.2015.00157 · Cited by 396
Metadata
- Authors
- Bonate, P. L., Arthaud, L., Cantrell, W. R., Stephenson, K., Secrist, J. A., & Weitman, S.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2006-10
- Volume
- 5
- Issue
- 10
- Pages
- 855-863
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W1963779075
- Cited by
- 257
- References
- 24
- FWCI
- 1.28
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.